In vivo and in vitro liver cancer metabolism observed with hyperpolarized [5-13C]glutamine

Journal of Magnetic Resonance

Volumn 232, Issue , 2013, Pages 45-52

  Cabella, C ^a   Karlsson, M ^b   Canape C ^c   Catanzaro, G ^a   Serra, S Colombo ^a   Miragoli, L ^a   Poggi, L ^a   Uggeri, F ^a   Venturi, L ^c   Jensen, P R ^b   Lerche, M H ^b   Tedoldi, F ^a  

^a Bracco Imaging SpA   (Italy)

^b Albeda Research   (Denmark)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

Dynamic nuclear polarization; Glutamine; Liver cancer

Indexed keywords

DISEASES; DRUG THERAPY; ENZYME ACTIVITY; ENZYMES; MAGNETIC RESONANCE SPECTROSCOPY; METABOLISM; PHYSIOLOGY; TUMORS;

BIOLOGICAL MODELS; CANCER DEVELOPMENT; DYNAMIC NUCLEAR POLARIZATION; ESSENTIAL AMINO ACIDS; GLUTAMINE; LIVER CANCERS; MITOCHONDRIAL ENZYMES; STRONG CORRELATION;

AMINO ACIDS;

ANIMALIA; RATTUS;

EID: 84885597727     PISSN: 10907807     EISSN: 10960856     Source Type: Journal    
DOI: 10.1016/j.jmr.2013.04.010     Document Type: Article

References (31)

1. R.J. DeBerardinis, A. Mancuso, E. Daikhin, I. Nissim, M. Yudkoff, S. Wehrli, C.B. Thompson, Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis, PNAS 104 (49) (2007) 19345-19350.
2. R.J. De Berardinis, N. Sayed, D. Ditsworth, C.B. Thompson, Brick by brick: metabolism and tumor cell growth, Curr. Opin. Genet. Dev. 18 (1) (2008) 54- 61. (Pubitemid 351694453)
3. R.J. DeBerardinis, T. Cheng, Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer, Oncogene 29 (3) (2010) 313-324.
4. M. Linder-Horowitz, W.E. Knox, H.P. Morris, Glutaminase activities and growth rates of rat hepatomas, Cancer Res. 29 (1969) 1195-1199.
5. J. Wang, J.W. Erickson, R. Fuji, S. Ramachandran, P. Gao, R. Dinavahi, K.F. Wilson, A.L.B. Ambrosio, S.M.G. Dias, C.V. Dang, R.A. Cerione, Targeting mitochondrial glutaminase activity inhibits oncogenic transformation, Cancer Cell 18 (2010) 207-219.
6. W.H. Koppenol, P.L. Bounds, C.V. Dang, Otto Warburg's contributions to current concepts of cancer metabolism, Nat. Rev. 11 (2011) 325-337.
7. P. Gao, I. Tchernyshyov, T. Chang, Y. Lee, K. Kita, T. Ochi, K. Zeller, A.M. De Marzo, J.E. Van Eyk, J.T. Mendell, C.V. Dang, C-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism, Nature 458 (7239) (2009) 762-765.
8. E.G.W. ter Voert, L. Heijmen, H.W.M. van Laarhoven, A. Heerschap, In vivo magnetic resonance spectroscopy of liver tumors and metastases, World J. Gastroenterol. 17 (2011) 5133-5149.
9. J.H. Ardenkjær-Larsen, B. Fridlund, A. Gram, G. Hansson, L. Hansson, M.H. Lerche, R. Servin, M. Thaning, K. Golman, Increase in signal-to-noise ratio of >10, 000 times in liquid-state NMR, PNAS 100 (18) (2003) 10158-10163. (Pubitemid 37071849)
10. K.M. Brindle, S.E. Bohndiek, F.A. Gallagher, M.I. Kettunen, Tumor imaging using hyperpolarized 13C magnetic resonance spectroscopy, Magn. Reson. Med. 66 (2011) 505-519.
11. K. Golman, R.I. Zandt, M. Lerche, R. Persson, J.H. Ardenkjær- Larsen, Metabolic imaging by hyperpolarized 13C magnetic resonance imaging for in vivo tumor diagnosis, Cancer Res. 66 (2006) 10855-10860. (Pubitemid 44876982)
12. K. Golman, R.I. Zandt, M. Thaning, Real-time metabolic imaging, PNAS 103 (30) (2006) 11270-11275. (Pubitemid 44156508)
13. S.E. Day, M.I. Kettunen, F.A. Gallagher, D. Hu, M. Lerche, J. Wolber, K. Golman, J.H. Ardenkjaer-Larsen, K.M. Brindle, Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy, Nat. Med. 11 (13) (2007) 1382-1387. (Pubitemid 350073590)
14. F.A. Gallagher, M.I. Kettunen, S.E. Day, M.H. Lerche, K. Brindle, 13C MR spectroscopy measurements of glutaminase activity in human hepatocellular carcinoma cells using hyperpolarized13C-labeled glutamine, Magn. Reson. Med. 60 (2008) 253-257.
15. H. Dafni, P.E.Z. Larson, S. Hu, H.A.I. Yoshihara, C.S. Ward, H.S. Venkatesh, C. Wang, X. Zhang, D.B. Vigneron, S.M. Ronen, Hyperpolarized 13C spectroscopic imaging informs on hypoxia-inducible Factor-1 and Myc activity downstream of platelet-derived growth factor receptor, Cancer Res. 70 (19) (2010) 7400- 7410.
16. W. Qu, Z. Zha, B.P. Lieberman, A. Mancuso, M. Stetz, R. Rizzi, K. Ploessl, D. Wise, C. Thompson, H.F. Kung, Facile synthesis [5-13C-4-2H2]- LGlutamine for hyperpolarized MRS imaging of cancer cell metabolism, Acad. Radiol. 18 (2011) 932-939.
17. M.P. Bartolomeo, F. Maisano, Validation of a reversed-phase HPLC method for quantitative amino acid analysis, J. Biomol. Tech. 17 (2006) 131-137.
18. Y. Guo, R. Klein, R.A. Omary, G. Yang, A.C. Larson, Highly malignant intrahepatic metastatic hepatocellular carcinoma in rats, Am. J. Trans. Res. 3 (1) (2011) 114-120.
19. K. Arii, H. Kobayashi, T. Kai, Y. Kokuba, Degradation kinetics of L-glutamine in aqueous solution, Eur. J. Pharm. Sci. 9 (1999) 75-78. (Pubitemid 29430195)
20. S. Budavari, M.J. O'Neal, A. Smith, P.E. Heckelman, J.F. Kinneary (Eds.), The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals, 12th ed., Merck & Co., Whitehouse Station, NJ, 1996.
21. P.R. Jensen, M. Karlsson, S. Meier, J.Ø. Duus, M.H. Lerche, Hyperpolarized amino acids for in vivo assays of transaminase activity, Chemistry 15 (39) (2009) 10010-10012.
22. M. Karlsson, P.R. Jensen, J.Ø. Duus, S. Meier, M.H. Lerche, Development of dissolution DNP-MR substrates for metabolic research, Appl. Magn. Reson. 43 (2012) 223-236.
23. P. Melnikov, L.Z. Zanoni, Clinical effects of cesium intake, Biol. Trace Elem. Res. 135 (1-3) (2010) 1-9.
24. F.A. Gallagher, M.I. Kettunen, S.E. Day, D. Hu, J.H. Ardenkjær- Larsen, R.I. Zandt, P.R. Jensen, M. Karlsson, K. Golman, M.H. Lerche, K.M. Brindle, Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate, Nature 453 (2008) 540-544.
25. U. Haberkorn, M.E. Bellemann, G. Brix, H. Kamencic, I. Morr, U. Traut, A. Altmann, J. Doll, J. Blatter, R. Kinscherf, Apoptosis and changes in glucose transport early after treatment of Morris hepatoma with gemcitabine, Eur. J. Nucl. Med. 28 (2001) 418-425. (Pubitemid 32260907)
26. K.R. Hande, Etoposide: four decades of development of a topoisomerase II inhibitor, Eur. J. Cancer 34 (10) (1998) 1514-1521. (Pubitemid 28446331)
27. E. Chiavazza, E. Kubala, C.V. Gringeri, S. Düwel, M. Durst, R.F. Schulte, M.I. Menzel, Earth's magnetic field enabled scalar coupling relaxation of 13C nuclei bound to fast-relaxing quadrupolar 14N in amide groups, J. Magn. Reson. (2012), http://dx.doi.org/10.1016/j.jmr.2012.11.016.
28. J. Kurhanewicz, D.B. Vigneron, K. Brindle, E.Y. Chekmenev, A. Comment, C.H. Cunningham, R.J. DeBerardinis, G.G. Green, M.O. Leach, S.S. Rajan, R.R. Rizi, B.D. Ross, W.S. Warren, C.R. Malloy, Neoplasia 13 (2) (2011) 81-97.
29. B.P. Bode, W. Sauba, Modulation of cellular proliferation alters glutamine transport and metabolism in human hepatoma cells, Ann. Surg. 220 (4) (1994) 411-424. (Pubitemid 24323438)
30. J.D. McGivan, Rat hepatoma cells express novel transport systems for glutamine and glutamate in addition to those present in normal rat hepatocytes, Biochem. J. 330 (1998) 255-260. (Pubitemid 28075748)
31. S. Suzukia, T. Tanakaa, M.V. Poyurovskyc, H. Naganoa, T. Mayamaa, S. Ohkubod, M. Lokshinc, H. Hosokawae, T. Nakayamae, Y. Suzukif, S. Suganof, E. Satog, T. Nagaog, K. Yokotea, I. Tatsunoa, C. Privesc, Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species, PNAS 107 (16) (2010) 7461-7466.